Innovation Pipeline 2021

The Innovation Pipeline features academic innovators  and pre-seed stage companies working on incredible, cutting edge science. They have been selected to highlight their discoveries at the virtual Life Sciences Summit and the featured innovators will be available for discussions throughout the live event – meetings may be scheduled via the event partnering system.

Canopy, Katonah, NY: Canopy’s patented see-through respirator is a radical re-invention of the N95 which improves healthcare worker safety, nearly eliminates the 7400 tons of daily N95 landfill waste, improves the patient experience, and lowers costs for health systems.
Joe Rosenberg, Founder & CEO

Culnexin, New York, NY: Developing small molecule therapeutics against a novel target, with applications in precision oncology, immuno-oncology as well as combination therapy. Suman Lal, CEO

Lime Therapeutics, New York, NY: A Sloan Kettering spinout aiming to create a new class of therapies targeting lipid metabolism in cancers and neurodegenerative disorders.

Remedium Bio, Needham, MA : Gene therapy company streamlining development by employing novel combinations of proven technologies, including a first-in-class disease-modifying osteoarthritis treatment based on a clinically proven mechanism that has demonstrated the ability to reverse the disease. Frank Luppino, President and CEO www.remedium-bio.com

View our 2020 Pipeline Cafe participants here.